MYLAN-NEVIRAPINE
MYLAN-NEVIRAPINE
Approved
DIN Number
02387727
Drug Class
Human
Market Date
Jun 20, 2012
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02387727
AIG Number0134602001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AG01 NEVIRAPINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
NEVIRAPINEActive
Strength: 200 MG
Monograph: NEVIRAPINE